Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial
MEK抑制剂对BRAF突变型黑色素瘤BRAF/MEK抑制剂联合治疗的贡献:随机、开放标签、III期COLUMBUS试验的第二部分
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.22.02322.
Paolo A Ascierto,Reinhard Dummer,Helen J Gogas,Ana Arance,Mario Mandala,Gabriella Liszkay,Claus Garbe,Dirk Schadendorf,Ivana Krajsova,Ralf Gutzmer,Vanna Chiarion-Sileni,Caroline Dutriaux,Jan Willem B de Groot,Naoya Yamazaki,Carmen Loquai,Caroline Robert,Keith T Flaherty